Cargando…
Pulmonary drug delivery for acute respiratory distress syndrome
The acute respiratory distress syndrome (ARDS) is a life-threatening condition that causes respiratory failure. Despite numerous clinical trials, there are no molecularly targeted pharmacologic therapies to prevent or treat ARDS. Drug delivery during ARDS is challenging due to the heterogenous natur...
Autores principales: | Fei, Qinqin, Bentley, Ian, Ghadiali, Samir N., Englert, Joshua A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851918/ https://www.ncbi.nlm.nih.gov/pubmed/36682407 http://dx.doi.org/10.1016/j.pupt.2023.102196 |
Ejemplares similares
-
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
por: Zoulikha, Makhloufi, et al.
Publicado: (2022) -
Pulmonary hypertension due to acute respiratory distress
syndrome
por: Ñamendys-Silva, S.A., et al.
Publicado: (2014) -
Pulmonary sarcoidosis presenting with acute respiratory distress syndrome
por: Arondi, Sabrina, et al.
Publicado: (2016) -
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
por: Gierhardt, Mareike, et al.
Publicado: (2021) -
Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation
por: Bobba, Christopher M., et al.
Publicado: (2021)